Literature DB >> 18336465

The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.

W W Hochreiter1.   

Abstract

Elevated levels of prostate-specific antigen (PSA) in men may result from a variety of causes, such as prostate cancer, benign prostatic hyperplasia, acute urinary tract infection, and bacterial prostatitis. In recent years, several studies have also demonstrated a relationship between chronic prostatitis/chronic pelvic pain syndrome and increased PSA levels. However, asymptomatic patients are not routinely screened for this diagnosis before transrectal biopsy is performed to rule out prostate cancer. These asymptomatic men with elevated PSA levels frequently have evidence of inflammation when their expressed prostatic secretions are examined, or on their prostate biopsy specimens. This raises the problem of appropriate evaluation in the presence of chronic prostatitis and elevated PSA levels--not only in prostate cancer screening programmes, but also in cancer-negative biopsy findings. Evidence from the literature indicates that antimicrobial treatment may lower the PSA levels to what is considered the normal range. Despite that, general recommendations for the practical management are lacking and undetected prostate cancer in men with chronic prostatitis remains a difficult issue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336465     DOI: 10.1111/j.1439-0272.2007.00820.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  13 in total

1.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

Review 2.  Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder.

Authors:  C F Heyns
Journal:  World J Urol       Date:  2011-07-01       Impact factor: 4.226

3.  Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer.

Authors:  Xingyan Liu; Zhiwei He; Cai-Hong Li; Guoliang Huang; Congcong Ding; Hong Liu
Journal:  Pathol Oncol Res       Date:  2011-06-18       Impact factor: 3.201

Review 4.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Elevated Serum PSA is Associated With Human Herpesvirus 8 Infection and Increased Circulating Cytokine Levels in Men From Tobago.

Authors:  Jill D Henning; Jaideep M Karamchandani; Luis A Bonachea; Clareann H Bunker; Alan L Patrick; Frank J Jenkins
Journal:  Prostate       Date:  2017-01-24       Impact factor: 4.104

6.  A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammation.

Authors:  An Gu Lee; Yong Hyeuk Choi; Sung Yong Cho; In Rae Cho
Journal:  Korean J Urol       Date:  2012-01-25

7.  Semen quality and associated reproductive indicators in middle-aged males: the role of non-malignant prostate conditions and genital tract inflammation.

Authors:  Kristo Ausmees; Paul Korrovits; Gennadi Timberg; Margus Punab; Reet Mändar
Journal:  World J Urol       Date:  2013-04-24       Impact factor: 4.226

8.  CD147 expression indicates unfavourable prognosis in prostate cancer.

Authors:  Zhao-dong Han; Xue-cheng Bi; Wei-jun Qin; Hui-chan He; Qi-shan Dai; Jun Zou; Yong-kang Ye; Yu-xiang Liang; Guo-hua Zeng; Zhi-nan Chen; Wei-de Zhong
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

9.  Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.

Authors:  Antonio B Porcaro; Daniele Mattevi; Giovanni Novella; Nicolò De Luyk; Paolo Corsi; Leonardo Bizzotto; Davide De Marchi; Marco Sebben; Alessandro Tafuri; Davide Inverardi; Tania Processali; Maria A Cerruto; Matteo Brunelli; Salvatore Siracusano; Walter Artibani
Journal:  Curr Urol       Date:  2017-12-30

10.  Inflammatory changes in biopsy specimens from patients with suspected prostate cancer.

Authors:  Przemysław Adamczyk; Zbigniew Wolski; Romuald Butkiewicz; Joanna Nussbeutel; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.